Premarin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0046-0749

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Premarin (NDC 0046-0749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Premarin 01)

FDA Label Image

Premarin-25mg-vial.jpg (Premarin 02)

FDA Label Image

Premarin-25mg-carton.jpg (Premarin 03)

Premarin 25 mg intravenous injection powder label for conjugated estrogens USP by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The lyophilized powder is for reconstitution with sterile water. Label displays dosing, storage temperature (2° to 8°C), barcode, and imprint area instructions. For Rx only.*

FDA Label Image

Premarin 04

Premarin 25 mg injection, powder, lyophilized, for solution, packaged by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The label indicates it is for intravenous and intramuscular use. The packaging includes storage instructions at 2° to 8°C and preparation details with sterile water for injection. The label highlights the active ingredient conjugated estrogens USP and the product strength 25 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.